Literature DB >> 23579391

Stemming the global trade in falsified and substandard medicines.

Lawrence O Gostin1, Gillian J Buckley, Patrick W Kelley.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23579391     DOI： 10.1001/jama.2013.3048

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Ongoing challenges in pharmacovigilance.

Authors:  Gerald J Dal Pan
Journal:  Drug Saf       Date:  2014-01       Impact factor: 5.606

Review 2.  After counterfeit Avastin®--what have we learned and what can be done?

Authors:  Tim K Mackey; Raphael Cuomo; Camille Guerra; Bryan A Liang
Journal:  Nat Rev Clin Oncol       Date:  2015-03-03       Impact factor: 66.675

3.  The Falsified Medicines Directive: How to secure your supply chain.

Authors:  G Smith; J A Smith; D A Brindley
Journal:  J Generic Med       Date:  2014-09

4.  An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain.

Authors:  Raphael E Cuomo; Tim K Mackey
Journal:  BMJ Open       Date:  2014-12-02       Impact factor: 2.692

5.  Establishing good authentication practice (GAP) in secondary care to protect against falsified medicines and improve patient safety.

Authors:  Bernard D Naughton; James A Smith; David A Brindley
Journal:  Eur J Hosp Pharm       Date:  2015-10-01

6.  Quality of antimalarial drugs and antibiotics in Papua New Guinea: a survey of the health facility supply chain.

Authors:  Manuel W Hetzel; Madhu Page-Sharp; Nancy Bala; Justin Pulford; Inoni Betuela; Timothy M E Davis; Evelyn K Lavu
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

7.  Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism.

Authors:  Tim K Mackey; Bryan A Liang
Journal:  BMC Med       Date:  2013-10-31       Impact factor: 8.775

8.  Microbiological contamination in counterfeit and unapproved drugs.

Authors:  Dieter Pullirsch; Julie Bellemare; Andreas Hackl; Yvon-Louis Trottier; Andreas Mayrhofer; Heidemarie Schindl; Christine Taillon; Christian Gartner; Brigitte Hottowy; Gerhard Beck; Jacques Gagnon
Journal:  BMC Pharmacol Toxicol       Date:  2014-06-26       Impact factor: 2.483

9.  Global landscape assessment of screening technologies for medicine quality assurance: stakeholder perceptions and practices from ten countries.

Authors:  Lukas Roth; Ameena Nalim; Beth Turesson; Laura Krech
Journal:  Global Health       Date:  2018-04-25       Impact factor: 4.185

Review 10.  Falsified and substandard cardiovascular drugs in Africa: a need for continued monitoring strategies.

Authors:  Marie Antignac; Ibrahima Bara Diop; Diane Macquart de Terline; Melisande Bernard; Bernard Do; Méo Stéphane Ikama; Roland N'Guetta; Dadhi M Balde; Yessoufou Tchabi; Abdallahi Sidi Aly; Ibrahim Ali Toure; Patrick Zabsonre; Jean Marie F Damorou; Jean Laurent Takombe; Louise Boyer Chatenet; Kumar Narayanan; Eloi Marijon; Jean Philippe Empana; Xavier Jouven
Journal:  J Glob Health       Date:  2019-12       Impact factor: 4.413
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.